Long-term follow-up of the conventional versus no-touch isolation technique for resection of primary colon cancer (JCOG1006): randomized clinical trial
BJS Open · 2024
DOI: 10.1093/bjsopen/zrae133 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BJS Open, 2024. Verfasst von Koji Komori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan. Hauptthemen laut MEDLINE: Colonic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
Background
The Japan Clinical Oncology Group (JCOG) 1006 was a phase III trial of patients with clinical T3/T4 colon cancer comparing the no-touch isolation technique (‘No Touch’) with the conventional technique (‘Conventional’). The planned primary analysis at 3 years failed to confirm the superiority of the No Touch over the ‘Conventional’. The present study aimed to compare the ‘No Touch’ and ‘Conventional’ using long-term (6-year) follow-up data.
Methods
Patients aged 20–80 years who had a clinical classification of T3–4, N0–2, and M0 with histologically proven colon cancer were randomly assigned (1 : 1) to undergo open surgery using ‘Conventional’ or ‘No Touch’ techniques. The primary endpoint was disease-free survival.
Results
In total, 853 patients from 30 institutions were assigned to the ‘Conventional’ (427) or ‘No Touch’ (426) groups between June 2011 and November 2015. The 6-year disease-free survival was 70.3% and 69.4% for ‘Conventional’ and ‘No Touch’ arms respectively (HR 1.030; 95% c.i. 0.813 to 1.304; one-sided P = 0.60). The 6-year overall survival was 89.4% and 86.6% respectively (HR 1.276; 95% c.i. 0.902 to 1.807). The 6-year relapse-free survival was 78.9% and 75.0% respectively (HR 1.209; 95% c.i. 0.920 to 1.589). The 6-year liver relapse-free survival was 85.1% and 80.2% respectively (HR 1.311; 95% c.i. 0.961 to 1.787).
Conclusion
Long-term follow-up data did not support the superiority of ‘No Touch’ over ‘Conventional’ technique in patients with stages II and III colon cancer. These study findings indicate that the conventional technique is still standard surgery for managing colon cancers. Trial registration number UMIN000004957
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
- Department of Gastroenterological Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
- JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
- Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
- Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
ORCID-Profile: Junki Mizusawa, Yukihide Kanemitsu, Takaya Kobatake, Hiroshi Katayama
Förderung
- National Cancer Center
Zitieren
APA
Komori, K., Takii, Y., Mizusawa, J., Kanemitsu, Y., Shiozawa, M., Ohue, M., Ikeda, S., Kobatake, T., Hamaguchi, T., Katayama, H., & Fukuda, H. (2024). Long-term follow-up of the conventional versus no-touch isolation technique for resection of primary colon cancer (JCOG1006): randomized clinical trial. BJS Open. https://doi.org/10.1093/bjsopen/zrae133
Vancouver
Komori K, Takii Y, Mizusawa J, Kanemitsu Y, Shiozawa M, Ohue M, et al. Long-term follow-up of the conventional versus no-touch isolation technique for resection of primary colon cancer (JCOG1006): randomized clinical trial. BJS Open. 2024. doi:10.1093/bjsopen/zrae133
BibTeX
@article{Komori2024,
author = {Komori, Koji and Takii, Yasumasa and Mizusawa, Junki and Kanemitsu, Yukihide and Shiozawa, Manabu and Ohue, Masayuki and Ikeda, Satoshi and Kobatake, Takaya and Hamaguchi, Tetsuya and Katayama, Hiroshi and Fukuda, Haruhiko},
title = {Long-term follow-up of the conventional versus no-touch isolation technique for resection of primary colon cancer (JCOG1006): randomized clinical trial},
journal = {BJS Open},
year = {2024},
doi = {10.1093/bjsopen/zrae133}
}
EUVIMED